课题基金 / 基金详情

Advanced Training in Surgical Oncology

Advanced Training in Surgical Oncology
肿瘤外科高级培训
批准号:
8892093
负责人:
RAPHAEL BUENO
金额:
$22.51万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-03-01 至 2018-06-30

项目摘要

项目成果

RAPHAEL BUENO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application is submitted by Brigham and Women's Hospital (BWH), a Harvard- affiliated teaching hospital located in Boston, and requests funding to continue a training program for cancer surgeons, the Advanced Training in Surgical Oncology (ATSO) program. ATSO supports laboratory-based cancer research for surgical residents who wish to pursue a career in general surgical or thoracic oncology. The program is primarily directed toward residents from BWH, but also includes other Harvard-affiliated residencies and postgraduate programs throughout the United States. ATSO leaders also make a deliberate attempt to recruit applicants from underrepresented minorities. The overall goal of ATSO is to dramatically improve care of cancer patients by training surgeon-scientists who will devote their careers to studying and implementing biologically-based cancer treatment. This goal is particularly important now, as surgeons are at the forefront of the revolution in personalized medicine. The ATSO program achieves this aim by exposing surgical residents to the best discovery and translational research available in the Harvard system, placing them in laboratories led by mentors who are accomplished scientists and educators. ATSO includes formal didactic sessions to familiarize trainees with the fundamentals of basic, translational and clinical research, including programs in research ethics. Through the work of its Governance Board, ATSO provides frequent career development and progress review interactions with trainees and the ATSO itself is continually enriched through formal evaluations by its Advisory Board and the trainees themselves. Our well-established program has a solid record of success, with 91% of post-ATSO trainees from the last 10 years successfully pursuing a career in academic medicine. We look forward to improving this record even further by meeting the challenges of an ever-increasing societal need for talented, well-trained and well-supported surgeon-scientists.
期刊论文(78)
专著(0)
科研奖励(0)
会议论文
Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model.
大型动物模型中的纳米颗粒迁移和紫杉醇向区域淋巴结的递送。
DOI: 10.1016/j.jamcollsurg.2011.11.006
发表时间: 2012-03
期刊: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
影响因子: 5.2
作者: [Khullar, Onkar V., Griset, Aaron P., Gibbs-Strauss, Summer L., Chirieac, Lucian R., Zubris, Kimberly A. V., Frangioni, John V., Grinstaff, Mark W., Colson, Yolonda L.]
通讯作者: Colson, Yolonda L.
Shared T cell epitopes in epithelial tumors.
上皮肿瘤中共有的 T 细胞表位。
DOI: 10.1006/cimm.1995.1171
发表时间: 1995
期刊: Cellular immunology.
影响因子: --
作者: [Peoples,GE, Smith,RC, Linehan,DC, Yoshino,I, Goedegebuure,PS, Eberlein,TJ]
通讯作者: Eberlein,TJ
In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumour.
用 HER2/neu 衍生的肽在体外刺激卵巢肿瘤相关淋巴细胞,诱导针对自体肿瘤的细胞毒性。
DOI: 10.1016/s0960-7404(10)80030-1
发表时间: 1995
期刊: Surgical oncology
影响因子: --
作者: [Linehan,DC, Peoples,GE, Hess,DT, Summerhayes,IC, Parikh,AS, Goedegebuure,PS, Eberlein,TJ]
通讯作者: Eberlein,TJ
Approaches to immunotherapy of cancer: characterization of lymphokines as second signals for cytotoxic T-cell generation.
癌症免疫治疗方法:淋巴因子作为细胞毒性 T 细胞生成的第二信号的表征。
DOI: --
发表时间: 1991
期刊: Surgery
影响因子: 3.8
作者: [Bertagnolli,MM, Herrmann,SH, Pinto,VM, Schoof,DD, Eberlein,TJ]
通讯作者: Eberlein,TJ
50
    Lung Navigation System for Localizing and Resecting Nodules
    • 批准号:
      10198924
    • 项目类别:
    • 资助金额:
      $36.78万
    • 财政年份:
      2018
    • 负责人:
      RAPHAEL BUENO
    • 依托单位:
    Validation of Prognostic and Diagnostic molecular tests in Mesothelioma
    • 批准号:
      7219955
    • 项目类别:
    • 资助金额:
      $30.16万
    • 财政年份:
      2006
    • 负责人:
      RAPHAEL BUENO
    • 依托单位:
    Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma
    • 批准号:
      8332277
    • 项目类别:
    • 资助金额:
      $34.47万
    • 财政年份:
      2006
    • 负责人:
      RAPHAEL BUENO
    • 依托单位:
    Validation of Prognostic and Diagnostic molecular tests in Mesothelioma
    • 批准号:
      7568786
    • 项目类别:
    • 资助金额:
      $30.16万
    • 财政年份:
      2006
    • 负责人:
      RAPHAEL BUENO
    • 依托单位:
    海外基金